Michael Miller to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Michael Miller has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.142
-
Henderson RM, Lovato L, Miller ME, Fielding RA, Church TS, Newman AB, Buford TW, Pahor M, McDermott MM, Stafford RS, Lee DS, Kritchevsky SB. Effect of Statin Use on Mobility Disability and its Prevention in At-risk Older Adults: The LIFE Study. J Gerontol A Biol Sci Med Sci. 2016 11; 71(11):1519-1524.
Score: 0.117
-
Williamson JD, Launer LJ, Bryan RN, Coker LH, Lazar RM, Gerstein HC, Murray AM, Sullivan MD, Horowitz KR, Ding J, Marcovina S, Lovato L, Lovato J, Margolis KL, Davatzikos C, Barzilay J, Ginsberg HN, Linz PE, Miller ME. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. JAMA Intern Med. 2014 Mar; 174(3):324-33.
Score: 0.025